| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0115-1366-29 | 0115-1366 | HUMAN PRESCRIPTION DRUG | sevelamer carbonate | sevelamer carbonate | POWDER, FOR SUSPENSION | ORAL | 20201120 | N/A | ANDA | ANDA211316 | Amneal Pharmaceuticals of New York LLC | SEVELAMER CARBONATE | 2400 mg/1 | 90 PACKET in 1 CARTON (0115-1366-29) / 1 POWDER, FOR SUSPENSION in 1 PACKET (0115-1366-30) |
| 0115-1365-29 | 0115-1365 | HUMAN PRESCRIPTION DRUG | sevelamer carbonate | sevelamer carbonate | POWDER, FOR SUSPENSION | ORAL | 20201120 | N/A | ANDA | ANDA211316 | Amneal Pharmaceuticals of New York LLC | SEVELAMER CARBONATE | 800 mg/1 | 90 PACKET in 1 CARTON (0115-1365-29) / 1 POWDER, FOR SUSPENSION in 1 PACKET (0115-1365-30) |